Brief: Interpace Biosciences Q3 Revenue USD 12.295 Million
04/11/2024 21:30
Nov 04 (Reuters) - Interpace Biosciences Q3 net income USD 1.28 million. * Q3 operating income USD 1.905 million * Q3 gross profit USD 7.506 million * Q3 net income continuing operations USD 1.362 million * Q3 operating expenses USD 5.601 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million